BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6575541)

  • 21. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
    Pittman M; Treese S; Chen L; Frater JL; Nguyen TT; Hassan A; Kreisel F
    Arch Pathol Lab Med; 2013 Nov; 137(11):1610-8. PubMed ID: 24168498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytopathology of alpha chain disease involving the central nervous system and pleura.
    Kumar PV; Esfahani FN; Tabei SZ; Malekzadeh R
    Acta Cytol; 1988; 32(6):902-7. PubMed ID: 2462320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant lymphoma and cytology].
    Kurita S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1721-8. PubMed ID: 6764093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of central nervous system leukaemia.
    Ng SC; Tan Asmlt MK; Kuperan P; Lin HP
    Malays J Pathol; 1988 Aug; 10():65-8. PubMed ID: 3252079
    [No Abstract]   [Full Text] [Related]  

  • 26. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas.
    Fischer L; Jahnke K; Martus P; Weller M; Thiel E; Korfel A
    Haematologica; 2006 Mar; 91(3):429-30. PubMed ID: 16531273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebrospinal fluid cytodiagnosis using sedimentation chamber method].
    Möbius W
    Med Welt; 1970 May; 21():846-8. PubMed ID: 5525898
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cerebral lymphoma in AIDS: clinical study and clinicopathological correlations].
    Marelle L; Raphaël M; Henin D; Vazeux R; Schuller E; Piette JC; Poisson M; Gentilini M; Hauw JJ
    Rev Neurol (Paris); 1994; 150(2):123-32. PubMed ID: 7863152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-hodgkin lymphoma.
    Desai J; Mitnick RJ; Henry DH; Llena J; Sparano JA
    Cancer; 1999 Nov; 86(9):1840-7. PubMed ID: 10547559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple sclerosis with negative cerebrospinal fluid. Magnetic resonance differential diagnosis].
    Bastianello S; Gasperini C; Ristori G; Paolillo A; Girmenia F; Bozzao L
    Radiol Med; 1994 Dec; 88(6):749-51. PubMed ID: 7878231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid examination. An important ancillary procedure in neurologic diagnosis.
    Azam A
    Med Trial Tech Q; 1973; 20(2):179-89. PubMed ID: 4769403
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical aspects and pathogenesis of neurological complications due to malignant lymphomas].
    Mizutani T
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1118-20. PubMed ID: 12784681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary intraocular lymphoma: improving the diagnostic procedure.
    Karma A; von Willebrand EO; Tommila PV; Paetau AE; Oskala PS; Immonen IJ
    Ophthalmology; 2007 Jul; 114(7):1372-7. PubMed ID: 17324466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary lymphoma of the central nervous system: 20 years' experience in a referral hospital].
    Calderón-Garcidueñas AL; Pacheco-Calleros J; Castelán-Maldonado E; Nocedal-Rustrián FC
    Rev Neurol; 2008 Jan 16-31; 46(2):84-8. PubMed ID: 18247279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An evaluation of cerebrospinal fluid cytology in childhood leukaemias and lymphomas (author's transl)].
    Mouriquand C; Bachelot C; Breyton M; Girardot P
    Nouv Presse Med; 1981 Feb; 10(6):391-4. PubMed ID: 7220331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytological analysis of the cerebrospinal fluid. A comparison between cytological methods and other methods used in analysis of cerebrospinal fluid in 1,000 patients].
    Weckman N; Torsti E; Taskinen E
    Duodecim; 1969; 85(9):554-65. PubMed ID: 4186091
    [No Abstract]   [Full Text] [Related]  

  • 39. Ferritin and malignant hemopathies. I. Ferritin in cerebrospinal fluid as an indicator of central nervous system leukemic involvement.
    Dillmann E; López-Karpovitch X; Alvarez-Hernández X; Hurtado R; Córdova MS; González-Llaven J; Díaz-Maqueo JC
    Rev Invest Clin; 1982; 34(2):95-8. PubMed ID: 7123032
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system.
    Weinberg A; Li S; Palmer M; Tyler KL
    Ann Neurol; 2002 Nov; 52(5):543-8. PubMed ID: 12402250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.